Promoting Quality in Drug Manufacturing

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2004
Volume 28
Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content